S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

AeroVironment Investors Targeted in New Class Action Lawsuit

Investors who held AeroVironment common stock between June 25, 2025, and March 10, 2026, face a critical deadline as a class action lawsuit moves forward. The Philadelphia-based law firm Berger Montague is now representing shareholders seeking recovery following a series of significant stock price declines tied to the company's defense contracts.

AeroVironment Investors Targeted in New Class Action Lawsuit
Photo: Bio & News

The litigation centers on the collapse of the Satellite Communication Augmentation Resource (SCAR) program, a key project for the Arlington-based defense contractor. AeroVironment shares experienced sharp volatility starting January 20, 2026, when the company revealed a government-issued stop work order on its BADGER systems, triggering a 15.77% drop in share value. Market pressure intensified on March 2, 2026, after reports surfaced that the U.S. Space Force intended to pursue a new acquisition strategy, leading to a further 17.42% decline.

The situation culminated on March 10, 2026, when the company reported a $179.0 million operating loss for the third quarter of fiscal year 2026, which included a $151.3 million impairment charge. Following the formal termination of the SCAR contract and the news that the company would need to recompete for the program, the stock fell an additional 6.24%. Shareholders wishing to serve as lead plaintiffs must submit their applications by July 27, 2026.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!